Kazakhstan

Kazakhstan: An OTC and Pharma market full of potential

The young and fast-growing OTC and Pharma market in Kazakhstan is young but promising and full of opportunities for European markets. 

Background of the OTC and Pharma market in Kazakhstan

The OTC and pharma mar­ket in Kaza­khstan is young. After the col­lapse of the Soviet Union, Kaza­khstan lacked any estab­lished phar­ma­ceu­ti­cal com­pa­nies, infra­struc­ture, or expe­ri­ence. Nev­er­the­less, the 1990s saw the establishment of Kazakhstan’s first Pharma com­pa­nies, and, over time, more and more for­eign com­pa­nies found their way to the poten­tial mar­ket there, which is very much influ­enced by imports.

At present, the share of domestic manufacturers in the procurement of medicines and medical devices has grown to 30% and continues to grow steadily. 

All in all, Kaza­khstan is a very promis­ing coun­try with its growth bol­stered by the demand for inno­v­a­tive health­care prod­ucts such as pre­scrip­tion medications, med­ical devices, OTC and food sup­ple­ments, as well as for medical exper­tise. The consumer healthcare and pharma market of Kazakhstan should reach more than USD 1,32 billion by 2035 ex-factory, according to the Chameleon Pharma Consulting Group forecast.

Chameleon Pharma Consulting Group has devel­oped a sys­tem­atic part­ner search process that can iden­tify the most suit­able local part­ner for you in Kaza­khstan in only 10-12 weeks. Simply contact us for more details!